CAS NO: | 1210004-12-8 |
包装 | 价格(元) |
10mg | 电议 |
50mg | 电议 |
Cas No. | 1210004-12-8 |
别名 | 4-硝基苯基4-(3-苯氧基苄基)哌嗪-1-甲酸叔丁酯 |
化学名 | 4-nitrophenyl 4-(3-phenoxybenzyl)piperazine-1-carboxylate |
Canonical SMILES | O=C(N1CCN(CC2=CC=CC(OC3=CC=CC=C3)=C2)CC1)OC(C=C4)=CC=C4[N+]([O-])=O |
分子式 | C24H23N3O5 |
分子量 | 433.46 |
溶解度 | DMF: 5 mg/ml,DMSO: 1.25 mg/ml |
储存条件 | Store at -20°C |
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
产品描述 | JZL195 is a selective and efficacious dual fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) inhibitor with IC50s of 2 and 4 nM, respectively[1]. JZL195 produces near-complete blockade of FP-Rh labeling of both mouse brain FAAH and MAGL at concentrations as low as 100 nM (IC50 values of 13 and 19 nM, respectively)[1].JZL195 inhibits rat and human FAAH and MAGL enzymes with IC50 values in the range of ≈10-100 nM based on competitive ABPP assays[1]. JZL195 (20 mg/kg; i.p.) produces an antinociceptive response in the tail immersion assay[1]. References: |